Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) CAO Patricia Carr sold 163 shares of the business’s stock in a transaction dated Friday, June 7th. The shares were sold at an average price of $108.83, for a total value of $17,739.29. Following the transaction, the chief accounting officer now owns 6,596 shares in the company, […]
Avidity Partners Management LP lessened its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 38.7% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 489,119 shares of the specialty pharmaceutical company’s stock after selling 308,381 shares during the quarter. Jazz Pharmaceuticals […]
Avidity Partners Management LP cut its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 38.7% during the 4th quarter, Holdings Channel.com reports. The firm owned 489,119 shares of the specialty pharmaceutical company’s stock after selling 308,381 shares during the quarter. Jazz Pharmaceuticals makes up approximately 2.2% of Avidity Partners Management LP’s […]
RK Capital Management LLC trimmed its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 34.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 92,020 shares of the specialty pharmaceutical company’s stock after selling 48,875 shares during the period. […]
Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) was upgraded by equities researchers at StockNews.com from a “buy” rating to a “strong-buy” rating in a note issued to investors on Friday. JAZZ has been the subject of a number of other reports. Stifel Nicolaus upped their price target on shares of Jazz Pharmaceuticals from $225.00 to […]